The Latest Breaking News from Cologuard

Cologuard Is Working—So Why Isn’t Abbott Stock?

Abbott's stock fell 4% despite solid Q3 results, as it trimmed full-year sales guidance and announced plans to spin off its Nutrition business into a separate public company by 2027.

MarketBeat · Oct 22

Albert Pujols Has a New Mission Beyond Baseball: Fighting Colon Cancer, Celebrating Latino Pride and Chasing a World Series as Manager - EXCLUSIVE

Albert Pujols spent more than two decades building one of the most extraordinary careers in baseball history. Now, the Dominican legend is using his influence to encourage Latinos to take colorectal cancer screening seriously, while keeping his ambitions alive for a new chapter in Major League Baseball.

Latin Times · Oct 13

1 'Strong Buy' Healthcare Stock to Scoop Up After Its Latest FDA Win

This top-rated healthcare stock is poised for substantial growth after securing FDA approval for its innovative non-invasive cancer diagnostic.

Barchart · Oct 10, 2024